Search
for

    Sort by

    Community Join

    780-810 / 1000+ results
      PP405 Identity Research

      community PP405 Identity Research

      in Research  292 upvotes 7 months ago
      PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.

      community 2 year fin/min progress (age 27-29)

      in Progress Pictures  302 upvotes 2 years ago
      A user's two-year progress using 1mg of oral finasteride daily and twice daily application of 5% minoxidil solution for hair loss. The user experienced temporary side effects but is pleased with the results, and another user warns about the importance of consistent use for maintaining results.

      community Does anyone know of the actual effectiveness of the DP2 inhibitors?

      in Question  5 upvotes 8 years ago
      Setipiprant and Fevipiprant are questioned for their effectiveness in hair maintenance, with skepticism due to lack of convincing results beyond vellus hair growth. The user is satisfied with Minoxidil and Finasteride but is curious about the potential of DP2 inhibitors.

      community How is verteporfin doing in trials?

      in Chat  10 upvotes 2 years ago
      The conversation is about the progress of verteporfin in hair loss trials, with users expressing curiosity about its effectiveness and updates. Specific treatments mentioned include FUE (Follicular Unit Extraction) combined with verteporfin, with one reported case of donor area regrowth after a year, and three patients being monitored post-treatment by Dr. Bloxham with monthly updates on YouTube.

      community 3 hair transplants | 11,102 grafts | 28 yrs old | NW 6/7

      in Transplants  149 upvotes 1 year ago
      A 28-year-old underwent three hair transplants totaling 11,102 grafts at Eugenix, using finasteride and minoxidil to manage advanced hair loss. Despite limited density, the results are satisfactory, allowing the individual to feel presentable without a hat.

      community Best Microneedle Lengths To Stimulate Stem Cells

      in Microneedling  18 upvotes 2 years ago
      Microneedling with needle lengths of 1.5mm to 2.5mm to stimulate hair follicle stem cells for potential hair growth. Using needles longer than 2.5mm is not recommended due to risk of puncturing veins in the scalp. A dermastamp is suggested over a roller.

      community Is this regrowth * finasteride only *

      in Is this regrowth?  114 upvotes 6 months ago
      The user is using finasteride 1.25mg three times a week for hair regrowth and reports no significant side effects except watery semen initially. They also use a local caffeine shampoo and are considering haircuts to improve appearance.

      community ASCEplus HRLV Exosomes with microneedling

      in Product  1 upvotes 2 years ago
      The discussion is about using ASCEplus HRLB exosomes for hair loss treatment, which combines 10 billion exosomes with growth factors, nutrients, biotin, and copper tripeptide. The treatment is expensive and typically administered via scalp injections, but in Europe, it's done with microneedling.

      community 2 months in, I think it's working

      in Progress Pictures  817 upvotes 2 months ago
      The user reported positive progress in hair regrowth after two months using finasteride, topical minoxidil, microneedling, and ketoconazole, later switching to dutasteride. Some users doubted the authenticity of the results, while others were impressed and encouraged by the progress.

      community 32M, 5 year progress pictures

      in Journals / Progress Pictures  250 upvotes 1 year ago
      The user has been using finasteride, ketoconazole shampoo, oral minoxidil, and minoxidil foam for hair loss but feels their hair is not as thick as desired. They have stopped using RU58841 due to lack of results and are concerned about hair miniaturization despite these treatments.

      community Novel effect of sildenafil (cialis) on hair growth

      in Research/Science  19 upvotes 3 years ago
      Sildenafil (Viagra) shows potential for hair growth by enhancing dermal papilla cell proliferation and stimulating perifollicular vessel formation. Users discuss the possibility of using Cialis (tadalafil) similarly, noting its benefits and side effects.

      community 2 and a half years progress and update

      in Progress Pictures  316 upvotes 2 years ago
      After 2.5 years of using 1mg finasteride daily, 5% minoxidil foam twice daily, and weekly micro-needling, the user reports thicker, healthier hair without further loss. They noticed initial regrowth at 3 months, with significant improvement up to 18 months, and no negative side effects from the treatment.
      2 years progress pics - need advice

      community 2 years progress pics - need advice

      in Journals / Progress Pictures  128 upvotes 7 months ago
      The user shared progress pictures of hair loss treatment using finasteride, minoxidil, and microneedling, expressing hope for recovery after an 8-9 month break. They seek advice on restarting treatment and are optimistic about regaining previous results.

      community Alfatradiol only for mild thinning

      in Product  1 upvotes 5 months ago
      Alfatradiol is considered safe but less effective than finasteride for hair loss. One user reported subtle regrowth using alfatradiol with finasteride and minoxidil, while another found alfatradiol ineffective.

      community 2 years progress (28M). Finally posting my results

      in Update  220 upvotes 1 year ago
      A 28-year-old shared his 2-year hair loss treatment progress using finasteride, minoxidil, dermarolling, and Revita shampoo. He saw significant improvement, especially with minoxidil and dermarolling, and stressed consistency.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.